| Date Filed | Type | Description |
| 05/01/2023 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Sold 45,000 shares
@ $22.45, valued at
$1M
|
|
| 05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Sold 88,000 shares
@ $16.95, valued at
$1.5M
Sold 65,382 shares
@ $17.45, valued at
$1.1M
Sold 67,970 shares
@ $17.45, valued at
$1.2M
Sold 22,000 shares
@ $17.85, valued at
$392.7k
Granted 300,000 shares
@ $0
Paid exercise price by delivering 200,000 shares
@ $17.57, valued at
$3.5M
Exercised 115,852 options to buy
@ $1.23, valued at
$142.5k
Exercised 19,530 options to buy
@ $9.49, valued at
$185.3k
Exercised 67,970 options to buy
@ $9.49, valued at
$645k
|
|
| 01/05/2023 |
4
| Lian Brian (Director) has filed a Form 4 on SEELOS THERAPEUTICS, INC.|
Txns:
| Granted 50,000 options to buy
@ $0.81, valued at
$40.5k
|
|
| 01/04/2023 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 121,667 shares
@ $0
Paid exercise price by delivering 66,127 shares
@ $9.4, valued at
$621.6k
Granted 266,667 shares
@ $0
Paid exercise price by delivering 68,252 shares
@ $8.52, valued at
$581.5k
Paid exercise price by delivering 28,619 shares
@ $8.42, valued at
$241k
Granted 600,000 options to buy
@ $8.52, valued at
$5.1M
|
|
| 01/06/2022 |
4
| Lian Brian (Director) has filed a Form 4 on SEELOS THERAPEUTICS, INC.|
Txns:
| Granted 35,000 options to buy
@ $1.56, valued at
$54.6k
|
|
| 01/05/2022 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 36,319 shares
@ $4.88, valued at
$177.2k
Granted 173,333 shares
@ $0
Paid exercise price by delivering 26,432 shares
@ $4.62, valued at
$122.1k
Granted 390,000 options to buy
@ $4.88, valued at
$1.9M
|
|
| 09/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2020 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 55,500 shares
@ $0
Paid exercise price by delivering 19,192 shares
@ $6.25, valued at
$120k
|
|
| 01/21/2020 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 3,195 shares
@ $7.18, valued at
$22.9k
|
|
| 01/07/2020 |
4
| Lian Brian (Director) has filed a Form 4 on SEELOS THERAPEUTICS, INC.|
Txns:
| Granted 16,000 options to buy
@ $1.42, valued at
$22.7k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2019 |
4
| Lian Brian (Director) has filed a Form 4 on SEELOS THERAPEUTICS, INC.|
Txns:
| Granted 24,000 options to buy
@ $2.33, valued at
$55.9k
Granted 16,000 options to buy
@ $2.33, valued at
$37.3k
|
|
| 01/28/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/22/2019 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,333 shares
@ $8.78, valued at
$38k
|
|
| 01/03/2019 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 80,897 shares
@ $0
Granted 235,554 options to buy
@ $7.58, valued at
$1.8M
|
|
| 05/08/2018 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 10,086 shares
@ $4.22, valued at
$42.6k
|
|
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/23/2018 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 140,000 options to buy
@ $4.65, valued at
$651k
|
|
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/05/2017 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $1.23, valued at
$307.5k
Granted 34,931 options to buy
@ $1.23, valued at
$43k
|
|
| 03/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2016 |
4
| Lian Brian (President & CEO) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 125,000 options to buy
@ $2.15, valued at
$268.8k
|
|
| 02/16/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |